ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Monoclonal Antibodies against Hepatitis C Genotype 3a Virus Like Particle Inhibit Virus Entry in Cell Culture System

Das, Soma and Shetty, Rohini K and Kumar, Anuj and Shridharan, Radhika Nagamangalam and Tatineni, Ranjitha and Chi, Giriprakash and Mukherjee, Anirban and Das, Saumitra and Subbarao, Shaila Melkote and Karande, Anjali Anoop (2013) Monoclonal Antibodies against Hepatitis C Genotype 3a Virus Like Particle Inhibit Virus Entry in Cell Culture System. In: PLOS ONE, 8 (1).

[img]
Preview
PDF
jou_pon_8-1_e53619_2013.pdf - Published Version

Download (668kB) | Preview
Official URL: http://dx.doi.org/10.1371/journal.pone.0053619

Abstract

The envelope protein (E1-E2) of Hepatitis C virus (HCV) is a major component of the viral structure. The glycosylated envelope protein is considered to be important for initiation of infection by binding to cellular receptor(s) and also known as one of the major antigenic targets to host immune response. The present study was aimed at identifying mouse monoclonal antibodies which inhibit binding of virus like particles of HCV to target cells. The first step in this direction was to generate recombinant HCV-like particles (HCV-LPs) specific for genotypes 3a of HCV (prevalent in India) using the genes encoding core, E1 and E2 envelop proteins in a baculovirus expression system. The purified HCV-LPs were characterized by ELISA and electron microscopy and were used to generate monoclonal antibodies (mAbs) in mice. Two monoclonal antibodies (E8G9 and H1H10) specific for the E2 region of envelope protein of HCV genotype 3a, were found to reduce the virus binding to Huh7 cells. However, the mAbs generated against HCV genotype 1b (D2H3, G2C7, E1B11) were not so effective. More importantly, mAb E8G9 showed significant inhibition of the virus entry in HCV JFH1 cell culture system. Finally, the epitopic regions on E2 protein which bind to the mAbs have also been identified. Results suggest a new therapeutic strategy and provide the proof of concept that mAb against HCV-LP could be effective in preventing virus entry into liver cells to block HCV replication.

Item Type: Journal Article
Additional Information: Copyright for this article belongs to PUBLIC LIBRARY SCIENCE,USA
Department/Centre: Division of Biological Sciences > Biochemistry
Division of Biological Sciences > Microbiology & Cell Biology
Depositing User: Francis Jayakanth
Date Deposited: 18 Mar 2013 05:34
Last Modified: 18 Mar 2013 05:34
URI: http://eprints.iisc.ac.in/id/eprint/46080

Actions (login required)

View Item View Item